J. Musaazi

发表

Safety and efficacy of hydroxychloroquine for treatment of non-severe COVID-19 among adults in Uganda: a randomized open label phase II clinical trial

A. Kwizera, M. Kamya, W. Bazeyo, 2021, BMC Infectious Diseases.

Impact of vitamin D status and cathelicidin antimicrobial peptide on adults with active pulmonary TB globally: A systematic review and meta-analysis

M. Joloba, W. Worodria, D. Kateete, 2021, PloS one.

Feasibility of a multifaceted intervention to improve treatment initiation among patients diagnosed with TB using Xpert MTB/RIF testing in Uganda

A. Cattamanchi, B. Castelnuovo, Y. Manabe, 2022, PloS one.

Efficacy and safety of dolutegravir or darunavir in combination with lamivudine plus either zidovudine or tenofovir for second-line treatment of HIV infection (NADIA): week 96 results from a prospective, multicentre, open-label, factorial, randomised, non-inferiority trial.

P. Kaleebu, A. Siika, B. Castelnuovo, 2022, The lancet. HIV.

Durability of Second-Line Anti-Retroviral Therapy in a Resource-Limited Setting: An 11-Year Analytical Cohort

B. Castelnuovo, J. Musaazi, Ivan Lumu, 2022, SSRN Electronic Journal.

Prevalence and factors associated with psychological distress among patients on warfarin at the Uganda Heart Institute, Mulago Hospital

D. Akena, W. Muhwezi, J. Musaazi, 2022, BMC Psychiatry.

Elevated Aspergillus-specific antibody levels among HIV infected Ugandans with pulmonary tuberculosis

D. Denning, J. Fehr, B. Castelnuovo, 2017, BMC Pulmonary Medicine.

Loss to follow-up among children and adolescents growing up with HIV infection: age really matters

A. Rehman, R. Ferrand, T. Apollo, 2017, Journal of the International AIDS Society.

Risk factors for mortality among patients diagnosed with multi-drug resistant tuberculosis in Uganda- a case-control study

S. Zawedde-Muyanja, S. Dejene, Estella Birabwa, 2020, BMC Infectious Diseases.

Comparison of Löwenstein–Jensen and BACTEC MGIT 960 culture for Mycobacterium tuberculosis in people living with HIV

B. Ledergerber, J. Fehr, B. Castelnuovo, 2018, HIV medicine.

Outcomes in a Cohort of Patients Started on Antiretroviral Treatment and Followed up for a Decade in an Urban Clinic in Uganda

M. Kamya, B. Castelnuovo, A. Kiragga, 2015, PloS one.

Developing a Patient-Centered Community-Based Model for Management of Multi-Drug Resistant Tuberculosis in Uganda: A Mixed Methods Study

S. Zawedde-Muyanja, J. Musaazi, S. Turyahabwe, 2021 .

Boosted lopinavir vs boosted atazanavir in patients failing a NNRTI first line regimen in an urban clinic in Kampala

A. Kiragga, R. Parkes-Ratanshi, I. Mambule, 2014, Journal of the International AIDS Society.

Relationship between socioeconomic status and risk of sexually transmitted infections in Uganda: Multilevel analysis of a nationally representative survey

A. Kiragga, L. Atuhaire, A. Mujugira, 2018, International journal of STD & AIDS.

Anti‐retroviral therapy scale‐up and its impact on sex‐stratified tuberculosis notification trends in Uganda

J. Ross, Y. Manabe, S. Hermans, 2019, Journal of the International AIDS Society.

Risky sexual behavior among patients on long-term antiretroviral therapy: a prospective cohort study in urban and rural Uganda

P. Kaleebu, M. Kamya, D. Moore, 2018, AIDS Research and Therapy.

Antiretroviral concentration measurements as an additional tool to manage virologic failure in resource limited settings: a case control study

J. Fehr, S. Reynolds, B. Castelnuovo, 2019, AIDS Research and Therapy.

Task shifting for initiation and monitoring of antiretroviral therapy for HIV-infected adults in Uganda: The SHARE Trial.

A. Kambugu, B. Bartholow, J. Musinguzi, 2020, Journal of acquired immune deficiency syndromes.

Inadequate Monitoring in Advanced Stages of Disease with Lack of Supportive Counseling Increases Attrition among Patients on Antiretroviral Treatment at a Large Urban Clinic in Uganda

E. Katabira, A. Kambugu, R. Colebunders, 2014, Journal of the International Association of Providers of AIDS Care.

Different modalities of entry in a large urban clinic in Uganda and impact on outcomes of patients assessing HIV care and treatment

B. Castelnuovo, A. Kiragga, J. Musaazi, 2017, AIDS care.

Incidence rate of sexually transmitted infections among HIV infected patients on long-term ART in an urban and a rural clinic in Uganda

D. Moore, J. Birungi, S. Okoboi, 2019, BMC Public Health.

Nutritional status and its associated factors among HIV adolescents on second line regimen at Pediatric Infectious Diseases Clinic in Uganda

J. Ssenkusu, M. Nicol, S. Kitaka, 2022, Journal of HIV/AIDS & Social Services.

Nutritional status and its associated factors among HIV positive adolescents on Atazanavir-based regimen attending an urban clinic in Uganda

M. Nicol, J. Ssenkusu, S. Kitaka, 2020, medRxiv.

Burden of fungal asthma in Africa: A systematic review and meta-analysis

S. Fowler, D. Denning, B. Kirenga, 2019, PloS one.

Pharmacokinetics of levonorgestrel and etonogestrel contraceptive implants over 48 weeks with rilpivirine- or darunavir-based antiretroviral therapy.

C. Fletcher, P. Byakika-Kibwika, M. Siccardi, 2022, The Journal of antimicrobial chemotherapy.

Sensitivity and specificity of the mean corpuscular volume and CD4/CD8 ratio in discriminating between rifampicin resistant and rifampicin sensitive tuberculosis

J. Musaazi, Joseph Baruch Baluku, I. Andia-Biraro, 2020, Journal of clinical tuberculosis and other mycobacterial diseases.

Durability of switched therapy after failure of WHO-recommended antiretroviral therapy regimens in a resource-limited setting

B. Castelnuovo, J. Musaazi, Ivan Lumu, 2022, AIDS.

Quantifying retention during pre-antiretroviral treatment in a large urban clinic in Uganda

B. Castelnuovo, A. Kiragga, J. Musaazi, 2015, BMC Infectious Diseases.

Dolutegravir or Darunavir in Combination with Zidovudine or Tenofovir to Treat HIV.

A. Siika, B. Castelnuovo, A. Kiragga, 2021, The New England journal of medicine.

International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK

Raúl Tabarés Gutiérrez, Samit R. Joshi, H. Jessen, 2016, Journal of the International AIDS Society.

Baseline Xpert MTB/RIF ct values predict sputum conversion during the intensive phase of anti-TB treatment in HIV infected patients in Kampala, Uganda: a retrospective study

J. Fehr, Y. Manabe, A. Kambugu, 2021, BMC Infectious Diseases.

Risky sexual behavior among patients on long-term antiretroviral therapy: a prospective cohort study in urban and rural Uganda AIDS Research and Therapy

P. Kaleebu, M. Kamya, J. Birungi, 2019 .

International Congress of Drug Therapy in HIV Infection 2‐6 November 2014, Glasgow, UK

Samit R. Joshi, Charlene A Flash, Thomas Lengauer, 2014 .

Delayed Sputum Culture Conversion in Tuberculosis–Human Immunodeficiency Virus–Coinfected Patients With Low Isoniazid and Rifampicin Concentrations

B. Ledergerber, P. Denti, A. Jetter, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Low Antituberculosis Drug Concentrations in HIV-Tuberculosis-Coinfected Adults with Low Body Weight: Is It Time To Update Dosing Guidelines?

P. Denti, J. Fehr, A. Calcagno, 2019, Antimicrobial Agents and Chemotherapy.

Cohort profile of a study on outcomes related to tuberculosis and antiretroviral drug concentrations in Uganda: design, methods and patient characteristics of the SOUTH study

B. Ledergerber, J. Fehr, B. Castelnuovo, 2017, BMJ Open.

Evaluation of Community Perceptions and Prevention Practices Related to Ebola Virus as Part of Outbreak Preparedness in Uganda, 2020

Rose Apondi, M. Jalloh, Apophia Namageyo-Funa, 2022, Global Health: Science and Practice.

Patients who return to care after tracking remain at high risk of attrition: experience from a large HIV clinic, Uganda

E. Katabira, R. Colebunders, W. Worodria, 2015, International journal of STD & AIDS.

Perceived risk and risk reduction behaviours of female first‐degree relatives of breast cancer patients attending care at Uganda cancer institute

C. Osingada, A. Mwaka, D. Abila, 2022, Psycho-oncology.

Early Tracking after a Missed Return Visit Reduces the Proportion of Untraceable Patients at a Large HIV Clinic in Kampala, Uganda

E. Katabira, R. Colebunders, Stella Alamo-Talisuna, 2016, Journal of the International Association of Providers of AIDS Care.

Prevalence and Predictors of CD4+ T-Lymphocytopenia Among HIV-Negative Tuberculosis Patients in Uganda

W. Katagira, F. Bongomin, J. Musaazi, 2020, Research and reports in tropical medicine.

RRTM_A_252550 45..51

W. Katagira, F. Bongomin, J. Musaazi, 2020 .

Spectrum of antibiotic resistance in UTI caused by Escherichia coli among HIV-infected patients in Uganda: a cross-sectional study

J. Fehr, B. Castelnuovo, A. Kambugu, 2021, BMC Infectious Diseases.

Survival and predictors of mortality after completion of TB treatment among people living with HIV: a 5-year analytical cohort

A. Semeere, B. Castelnuovo, J. Musaazi, 2023, BMC Infectious Diseases.

Pharmacokinetics, SAfety/tolerability, and EFficacy of high-dose RIFampicin in tuberculosis-HIV co-infected patients on efavirenz- or dolutegravir-based antiretroviral therapy: study protocol for an open-label, phase II clinical trial (SAEFRIF)

K. Dooley, P. Denti, D. Sloan, 2020, Trials.

Estimating the effect of pretreatment loss to follow up on TB associated mortality at public health facilities in Uganda

A. Cattamanchi, B. Castelnuovo, Y. Manabe, 2020, PloS one.

Integrating interferon-gamma release assay testing into provision of tuberculosis preventive therapy is feasible in a tuberculosis high burden resource-limited setting: A mixed methods study

S. Muchuro, S. Zawedde-Muyanja, J. Mayito, 2022, PLOS global public health.

The contribution of late HIV diagnosis on the occurrence of HIV-associated tuberculosis

A. d’Arminio Monforte, C. Mussini, B. Castelnuovo, 2022, AIDS.

Developing a patient-centered community-based model for management of multi-drug resistant tuberculosis in Uganda: a discrete choice experiment

S. Zawedde-Muyanja, J. Musaazi, S. Turyahabwe, 2022, BMC Health Services Research.

Increased uptake of tuberculosis preventive therapy (TPT) among people living with HIV following the 100-days accelerated campaign: A retrospective review of routinely collected data at six urban public health facilities in Uganda

S. Okoboi, B. Castelnuovo, A. Kiragga, 2023, PloS one.

Prevalence and incidence of hypertension in a heavily treatment-experienced cohort of people living with HIV in Uganda

K. Petoumenos, B. Castelnuovo, R. Parkes-Ratanshi, 2023, PloS one.

Adherence monitoring methods to measure virological failure in people living with HIV on long-term antiretroviral therapy in Uganda

R. King, S. Okoboi, B. Castelnuovo, 2022, PLOS global public health.

Virological Outcome of Patients With HIV Drug Resistance Attending an Urban Outpatient Clinic in Uganda: A Need for Structured Adherence Counseling and Third-Line Treatment Options

J. Fehr, B. Castelnuovo, A. Kambugu, 2019, Journal of acquired immune deficiency syndromes.

Tuberculosis treatment success among rural and urban Ugandans living with HIV: a retrospective study.

A. Rehman, B. Castelnuovo, A. Kiragga, 2017, Public health action.

Treatment success of urban and rural Ugandans 101 Public Health Action

B. Castelnuovo, A. Kiragga, A. Kambugu, 2018 .

“It is not easy”: Experiences of people living with HIV and tuberculosis on Tuberculosis treatment in Uganda

R. King, M. Kesby, D. Sloan, 2023, Journal of Clinical Tuberculosis and Other Mycobacterial Diseases.

Decreased dolutegravir and efavirenz concentrations with preserved virological suppression in patients with TB and HIV receiving high-dose rifampicin.

K. Dooley, P. Denti, D. Sloan, 2022, Clinical Infectious Diseases.

A case for routine microbial diagnostics: Results from antimicrobial susceptibility testing in post-traumatic wound infections at a Ugandan tertiary care hospital

E. Mwaka, H. Kajumbula, J. Musaazi, 2023, PLOS global public health.

Microbiological Findings and Clinical Outcomes in Ugandan Patients with Infected Burn Wounds

Charles Kabugo, H. Kajumbula, J. Musaazi, 2023, European Burn Journal.

Public perceptions of Ebola vaccines and confidence in health services to treat Ebola,

Rose Apondi, D. Prybylski, M. Jalloh, 2023 .

A case for routine microbial diagnostics: Results from antimicrobial susceptibility testing in post-traumatic wound infections at a Ugandan tertiary care hospital

E. Mwaka, H. Kajumbula, J. Musaazi, 2023, PLOS global public health.

Dolutegravir pharmacokinetics in Ugandan patients with TB and HIV receiving standard- versus high-dose rifampicin

C. Sekaggya-Wiltshire, M. Lamorde, J. Musaazi, 2023, Antimicrobial agents and chemotherapy.

Community-based directly observed therapy is effective and results in better treatment outcomes for patients with multi-drug resistant tuberculosis in Uganda

S. Zawedde-Muyanja, J. Musaazi, S. Turyahabwe, 2023, BMC Health Services Research.

Switch to long-acting cabotegravir and rilpivirine in virologically suppressed adults with HIV in Africa (CARES): week 48 results from a randomised, multicentre, open-label, non-inferiority trial.

V. van Eygen, I. Mambule, J. Musaazi, 2024, The Lancet. Infectious diseases.

Low isoniazid and rifampicin concentrations in TB/HIV co-infected patients in Uganda

J. Fehr, B. Castelnuovo, A. Kambugu, 2014, Journal of the International AIDS Society.